by E-ALGOS Co-Authors Team | Dec 3, 2011 | Articles
A new Medtronic (NYSE:MDT) neurostimulation system that uses motion-sensor technology to automatically adjust stimulation levels in patients with chronic leg and back pain has won U.S. Food and Drug Administration approval. The AdaptiveStim RestoreSensor system...
by E-ALGOS Co-Authors Team | Nov 9, 2011 | Articles
ALISO VIEJO, Calif., Nov. 3, 2011 /PRNewswire/ — Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the enrollment of the first patient in the PRIME study. The PRIME study is a Phase II clinical trial investigating the use of AVP-923 for the treatment...
by Dimitris Papadopoulos MD Fellow Of Interventional Pain Practice (FIPP) | Oct 21, 2011 | Articles
The Journal Diseases of the Colon and Rectum recently published data from a multicenter, prospective trial showing that use of Medtronic’s InterStim Therapy via sacral nerve stimulation reduced incontinent episodes and improved quality of life in a majority of...
by E-ALGOS Co-Authors Team | Sep 19, 2011 | Conditions, Feautered Article, Lower Limbs Pain, Plantar Pain-Plantar Fascitis
Panos Symeonidis Orthopaedic Surgeon Foot & Ankle Specialist www.foot-ankle.gr Introduction Approximately one out of ten people will suffer from plantar heel pain at least once in their lives. Despite the fact that the symptom of plantar pain is so common, its...
by E-ALGOS Co-Authors Team | Sep 10, 2011 | Technology and Chronic pain
CE Mark approval expands treatment options for patients suffering from the pain and disability associated with intractable chronic migraine ST. PAUL, Minn.–(BUSINESS WIRE)–St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced...
